Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.

[1]  S. Henri,et al.  Induction of protective immunity against S.mansoni in mice vaccinated with Sm10-DLC , 1998 .

[2]  N. R. Bergquist,et al.  Schistosomiasis vaccine:research to development. , 1998, Parasitology today.

[3]  K. Hoffmann,et al.  Molecular Identification of a Schistosoma mansoni Tegumental Protein with Similarity to Cytoplasmic Dynein Light Chains* , 1996, The Journal of Biological Chemistry.

[4]  M. Guillaume,et al.  Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. , 1996, Vaccine.

[5]  N. R. Bergquist.  Controlling schistosomiasis by vaccination: A realistic option? , 1995 .

[6]  H. Dessein,et al.  Identification of a major T cell immunogen in the anti‐schistosome response of adult residents in an area endemic for Schistosoma mansoni , 1995, European journal of immunology.

[7]  R. Levy,et al.  Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma , 1993, Nature.

[8]  A. Dessein,et al.  Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area , 1992, European journal of immunology.

[9]  P. D. Smith,et al.  Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. , 1990, Journal of immunology.

[10]  V. Nussenzweig,et al.  Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria , 1990, The Journal of experimental medicine.

[11]  A. Reske-Kunz,et al.  Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. , 1988, Journal of immunology.

[12]  A. Prata,et al.  Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. , 1988, Journal of immunology.

[13]  P. Morrissey,et al.  Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. , 1987, Journal of immunology.

[14]  A. Burgess,et al.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. , 1977, The Journal of biological chemistry.

[15]  S. R. Smithers,et al.  The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms , 1965, Parasitology.

[16]  S. Henri,et al.  Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum. , 1999, Vaccine.

[17]  M. Wright,et al.  The functional and immunological significance of some schistosome surface molecules. , 1991, Parasitology today.